A growing number of clinicians rely on AdaptDx to detect age-related macular degeneration in their adult patients. Our customers tell the story of how they’re fighting against blindness caused by AMD.
The marketing package MacuLogix provides to their customers is the best I have seen with any equipment company!
Starting therapy early may have huge benefits when we project forward another 10 or 20 years. I believe this device is helping me save vision for many people.
AdaptDx has really helped me care for my patients. It has helped me find macular degeneration a lot earlier and be able to proactively treat this for my patients.
When we started using the AdaptDx, we weren’t sure how the technology was going to be received. But we found that using it in the office has made us better clinicians and has improved the quality of life for our patients. I honestly can’t see myself practicing without the AdaptDx at this point.
I have been in eye care since the late 90s and I remember that macular degeneration was just a condition that was very difficult to detect and even once detected, difficult to do anything about it. So essentially we were just watching patients go blind. Now that we have the AdaptDx it’s made a world of a difference in diagnosing patients.
The primary goal of every optometrist is to maximize and preserve the vision of their patients. The AdaptDx is the best device available for the earliest detection of reduced dark adaptation of the retina, usually secondary to AMD. Early detection gives my patients the best chance for long term retention of their vision, thereby achieving their vision goals and my practice goals.
I started using my AdaptDx this past July (2017), and it has already completely changed my approach to AMD for the better. In terms of both detecting undiagnosed AMD and confirming patients with early AMD, I can say with confidence that it's preserving future vision for my patients.
The AdaptDx has been a great addition to my office. This device allows me to find patients with AMD much sooner than we've ever been able to do. We know that 1 out of 3 Americans over the age of 75 has some form of AMD. But why wait until it's obvious to start therapy?
We have a large retirement population here in Myrtle Beach, so we see a lot of AMD. We invested in the AdaptDx because we know it’s going to help us take better care of our AMD patients, as well as identify so many others who are at risk for developing this devastating disease.
There is no better way to grow a corporate practice then having the newest and most advanced technology like the AdaptDx. This makes my practice stand out from other practices.